Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children

DM Rabi, KA McBrien, R Sapir-Pichhadze… - Canadian Journal of …, 2020 - Elsevier
Hypertension Canada's 2020 guidelines for the prevention, diagnosis, risk assessment, and
treatment of hypertension in adults and children provide comprehensive, evidence-based …

Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association

RM Carey, DA Calhoun, GL Bakris, RD Brook… - …, 2018 - Am Heart Assoc
Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a
patient despite the concurrent use of 3 antihypertensive drug classes, commonly including a …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled …

M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly… - The Lancet, 2021 - thelancet.com
Background Endovascular renal denervation reduces blood pressure in patients with mild-to-
moderate hypertension, but its efficacy in patients with true resistant hypertension has not …

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - European heart …, 2018 - academic.oup.com
Aims The expression of GADD153 (growth arrest and DNA damage-inducible gene 153), an
apoptosis-regulated gene, increases during endoplasmic reticulum (ER) stress. How …

[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice

MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study

GL Hundemer, GC Curhan, N Yozamp… - The lancet Diabetes & …, 2018 - thelancet.com
Background Mineralocorticoid receptor (MR) antagonists are the recommended medical
therapy for primary aldosteronism. Whether this recommendation effectively reduces …

[PDF][PDF] Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

B Williams, G Mancia, W Spiering, E Agabiti Rosei… - Rev Esp …, 2019 - peroxfarma.com
La tarea de elaboración de GPC incluye la creación de herramientas educativas y
programas de implementación de las recomendaciones. Para su implementación, se …

Effects of lifestyle modification on patients with resistant hypertension: results of the TRIUMPH randomized clinical trial

JA Blumenthal, AL Hinderliter, PJ Smith, S Mabe… - Circulation, 2021 - Am Heart Assoc
Background: Although lifestyle modifications generally are effective in lowering blood
pressure (BP) among patients with unmedicated hypertension and in those treated with 1 or …

[PDF][PDF] 2013 ESH/ESC Guidelines for the management of arterial hypertension

G Mancia, R Fagard, K Narkiewicz… - Arterial …, 2013 - journals.viamedica.pl
Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …